Time 1 (T1): Valegos/Merck is made aware of the how his company has the ability to produce a drug to cure river blindness.
Time 2 (T2): Valegos/Merck decides to go ahead and begin R&D (spending lots of company funds) on the River blindness drug.
Time 3 (T3): Valegos/Merck begins distributing the drug to countries that need the drug to cure river blindness.
1.According to Freeman, who or what counts as stakeholders of the corporation?
2.As the head of an organization, what is the point of knowing when your stakeholders’ status begins and ends?
3.At what point do the children suffering from river blindness “count” as Merck’s stakeholders? (Explain your reasoning.)
4.Now that you have answered #1, #2, and #3, why is this information important for Valegos regarding how he decides to proceed and provide the cure for river blindness in the future?